Publicaciones en colaboración con investigadores/as de University of Sassari (13)

2023

  1. Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia

    Archivos de Bronconeumologia, Vol. 59, Núm. 2, pp. 90-100

2021

  1. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

    Chest, Vol. 159, Núm. 1, pp. 58-72

  2. Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study (European Journal of Clinical Microbiology & Infectious Diseases, (2020), 39, 8, (1513-1525), 10.1007/s10096-020-03870-3)

    European Journal of Clinical Microbiology and Infectious Diseases

2020

  1. Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases

    European Respiratory Journal

  2. Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective (BMC Infectious Diseases, (2018), 18, 1, (677), 10.1186/s12879-018-3565-z)

    BMC Infectious Diseases

  3. Should we worry about bedaquiline exposure in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis?

    European Respiratory Journal

  4. Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts

    Pulmonology, Vol. 26, Núm. 4, pp. 233-240

  5. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

    Emerging Infectious Diseases, Vol. 26, Núm. 11, pp. 2709-2712

2019

  1. An international perspective on hospitalized patients with viral community-acquired pneumonia

    European Journal of Internal Medicine, Vol. 60, pp. 54-70

  2. Prevalence and etiology of community-acquired pneumonia in immunocompromised patients

    Clinical Infectious Diseases, Vol. 68, Núm. 9, pp. 1482-1493

  3. Time and age trends in smoking cessation in Europe

    PLoS ONE, Vol. 14, Núm. 2

2017

  1. Effectiveness and safety of bedaquilinecontaining regimens in the treatment of MDR- and XDR-TB: A multicentre study

    European Respiratory Journal, Vol. 49, Núm. 5

2016

  1. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study

    The Lancet Infectious Diseases, Vol. 16, Núm. 12, pp. 1364-1376